Neurocrine Bioscience buy Deutsche Bank Aktiengesellschaft
Start price
12.12.23
/
50%
€111.60
Target price
12.12.24
€126.18
Performance (%)
20.34%
Price
09:44
€134.30
Summary
This prediction is currently active. The prediction currently has a performance of 20.34%. This prediction currently runs until 12.12.24. The prediction end date can be changed by Deutsche_Bank_Aktien at any time. Deutsche_Bank_Aktien has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Neurocrine Bioscience | -0.924% | -0.924% |
iShares Core DAX® | -0.116% | 1.953% |
iShares Nasdaq 100 | -2.733% | -1.273% |
iShares Nikkei 225® | -1.721% | 3.263% |
iShares S&P 500 | -1.527% | 0.194% |
Comments by Deutsche_Bank_Aktien for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating and a $136.00 price target on the stock.
Ratings data for NBIX provided by MarketBeat